EPISODE · Jul 17, 2025 · 25 MIN
Prime Medicine's new CEO Allan Reine walks us through the prime editing company's new focused pipeline
from BiotechTV - News · host BiotechTV
He describes the benefits of prime editing, walks us through human proof-of-concept data that was announced in a patient with Chronic Granulomatous Disease, and explains the rationale to focus on Wilson's Disease, Alpha-1 Antitrypsin Deficiency, Cystic Fibrosis, and the company's CAR-T partnership with Bristol Myers Squibb.
What this episode covers
He describes the benefits of prime editing, walks us through human proof-of-concept data that was announced in a patient with Chronic Granulomatous Disease, and explains the rationale to focus on Wilson's Disease, Alpha-1 Antitrypsin Deficiency, Cystic Fibrosis, and the company's CAR-T partnership with Bristol Myers Squibb.
NOW PLAYING
Prime Medicine's new CEO Allan Reine walks us through the prime editing company's new focused pipeline
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.